OpenAlex
PricingAboutJobs
Log inGet started
Work

A key in vivo antitumor mechanism of action of natural product-based brassinins is inhibition of indoleamine 2,3-dioxygenase

HTML

Year: 2007
Type: article
Source: Oncogene
DOI: 10.1038/sj.onc.1210939
Authors: T Banerjee, J B DuHadaway, P Gaspari, E Sutanto-Ward, D H Munn, A L Mellor, W P Malachowski, G C Prendergast, A J Muller
Institutions: NewLink Genetics (United States), Lankenau Institute for Medical Research, Bryn Mawr College, Augusta University, Thomas Jefferson University, Sidney Kimmel Cancer Center
Language: English

Topic: Cancer Immunotherapy and Biomarkers
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: brassinin, indoleamine 2,3-dioxygenase inhibition, phytoalexins, anticancer mechanism, tumor immune evasion, chemoprevention, mammary tumors, MMTV-Neu mice, melanoma, T cell immunity, natural products
SDG: Good health and well-being

Open Access status: closed

Funders: U.S. Department of Defense, Lance Armstrong Foundation, Concern Foundation, Charlotte Geyer Foundation, National Institutes of Health, National Cancer Institute
Awards: Role of RHO in Farnesyltransferase Inhibitor Responses, RhoB Signaling in Cancer Suppression and Cell Suicide, IDO inhibitors for combinatorial cancer therapy
OpenAlex ID: W1966912859
FWCI: 5.293
Cites: 33
Cited by: 185
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms